BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25084203)

  • 21. Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia.
    Hartman A; van Schaik RH; van der Heiden IP; Broekhuis MJ; Meier M; den Boer ML; Pieters R
    Leuk Res; 2010 Feb; 34(2):154-9. PubMed ID: 19467705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients.
    Shalaby N; Zaki HF; Badary OA; Kamal S; Nagy M; Makhlouf D; Elnashar A; Elnadi E; Abdelshafi SA; Abouelnaga S; Saber MM
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1391-1409. PubMed ID: 38680001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia.
    Gregers J; Gréen H; Christensen IJ; Dalhoff K; Schroeder H; Carlsen N; Rosthoej S; Lausen B; Schmiegelow K; Peterson C
    Pharmacogenomics J; 2015 Aug; 15(4):372-9. PubMed ID: 25582575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
    Huang Z; Wang J; Qian J; Li Y; Xu Z; Chen M; Tong H
    Mol Med Rep; 2017 Jun; 15(6):3493-3498. PubMed ID: 28440407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.
    Yang QY; Hu YH; Guo HL; Xia Y; Zhang Y; Fang WR; Li YM; Xu J; Chen F; Wang YR; Wang TF
    Front Pharmacol; 2021; 12():771487. PubMed ID: 34955843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
    Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
    Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients.
    Renbarger JL; McCammack KC; Rouse CE; Hall SD
    Pediatr Blood Cancer; 2008 Apr; 50(4):769-71. PubMed ID: 18085684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia.
    Erdélyi DJ; Kámory E; Zalka A; Semsei AF; Csókay B; Andrikovics H; Tordai A; Borgulya G; Magyarosy E; Galántai I; Fekete G; Falus A; Szalai C; Kovács GT
    Cell Immunol; 2006 Dec; 244(2):121-4. PubMed ID: 17434155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of increased lipoproteins levels on the disposition of vincristine in rat.
    Khalil HA; Belal TS; El-Yazbi AF; Hamdy DA
    Lipids Health Dis; 2016 Sep; 15(1):152. PubMed ID: 27613245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of vincristine toxicity with concomitant fluconazole prophylaxis in children with acute lymphoblastic leukemia.
    Teusink AC; Ragucci D; Shatat IF; Kalpatthi R
    Pediatr Hematol Oncol; 2012 Feb; 29(1):62-7. PubMed ID: 22304011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia.
    Gervasini G; de Murillo SG; Jiménez M; de la Maya MD; Vagace JM
    Gene; 2017 Sep; 628():72-77. PubMed ID: 28710036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement.
    Nazir HF; AlFutaisi A; Zacharia M; Elshinawy M; Mevada ST; Alrawas A; Khater D; Jaju D; Wali Y
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28623857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe Vincristine-induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study.
    Bosilkovska M; Ing Lorenzini K; Uppugunduri CR; Desmeules J; Daali Y; Escher M
    Clin Ther; 2016 Jan; 38(1):216-20. PubMed ID: 26565076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vincristine disposition in children with acute lymphoblastic leukemia.
    de Graaf SS; Bloemhof H; Vendrig DE; Uges DR
    Med Pediatr Oncol; 1995 Apr; 24(4):235-40. PubMed ID: 7700168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vincristine sulfate liposomal injection for acute lymphoblastic leukemia.
    Raj TA; Smith AM; Moore AS
    Int J Nanomedicine; 2013; 8():4361-9. PubMed ID: 24232122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.
    Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL
    Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G80A Single Nucleotide Polymorphism in Reduced Folate Carrier-1 Gene in a Mexican Population and its Impact on Survival in Patients with Acute Lymphoblastic Leukemia.
    Candelaria M; Ojeda J; Gutiérrez-Hernández O; Taja-Chayeb L; Vidal-Millán S; Dueñas-González A
    Rev Invest Clin; 2016; 68(3):154-62. PubMed ID: 27409003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
    Faganel Kotnik B; Grabnar I; Bohanec Grabar P; Dolžan V; Jazbec J
    Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of CYP1A1, GSTP1 and XRCC1 genes polymorphisms on toxicity and response to chemotherapy in childhood acute lymphoblastic leukemia.
    Abo-Bakr A; Mossallam G; El Azhary N; Hafez H; Badawy R
    J Egypt Natl Canc Inst; 2017 Sep; 29(3):127-133. PubMed ID: 28844589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.